Home » Gabrielle Simmons

Gabrielle Simmons


Gabrielle Simmons is a Manager at CBPartners.

Connect with Gabrielle Simmons



Published Articles

Parkinson’s Disease Clinical Trials: How Close Are We to Disease-Modifying Therapies?

PART I of CBPartners' CNS series: as the scientific and regulatory barriers in Parkinson’s disease are beginning to be addressed, biotechnology firms are developing innovative therapies based on academic studies showing potential therapeutic targets and pathways, which have been generated with increasing quantity over the past few years using genetic and pre-clinical studies.

Central Nervous System (CNS) Drug Development Strategy: What is the Role of External Investment in this High-Risk Disease Space?

PART I of CBPartners' CNS series: the concept of external investment may represent a positive trend in the neuroscience space where different size firms are focused on their comparative strengths.

Alzheimer’s Disease Clinical Trials: Where Do We Go Now?

PART II of CBPartners' CNS series: